Cargando…
Comparison of the performance of a chemiluminescence assay and an ELISA for detection of anti-GBM antibodies
OBJECTIVE: Autoantibodies to the α3 chain noncollagen 1 domain of type IV collagen (α3(IV)NC1) are a serological hallmark in the diagnosis of anti-glomerular basement membrane (GBM) disease. The objective of our study was to compare the performance of anti-glomerular basement membrane (GBM) antibody...
Autores principales: | Tan, Ying, Pang, Wei, Jia, Xiaoyu, Zhao, Ming-hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968565/ https://www.ncbi.nlm.nih.gov/pubmed/31885301 http://dx.doi.org/10.1080/0886022X.2019.1702056 |
Ejemplares similares
-
Investigation of Anti-Toxocara Antibodies in Epileptic Patients and Comparison of Two Methods: ELISA and Western Blotting
por: Zibaei, Mohammad, et al.
Publicado: (2013) -
A Case of Simultaneous, Biopsy-Proven, Classic, ANCA-Positive Wegener's Granulomatosis and Anti-GBM Disease, but without Detectible Circulating Anti-GBM Antibodies
por: Gmurczyk, Aleksandra, et al.
Publicado: (2010) -
Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody
por: Yang, Shuo, et al.
Publicado: (2019) -
Comparison of Chemiluminescence Enzyme Immunoassay (Cl-ELISA) with Colorimetric Enzyme Immunoassay (Co-ELISA) for Imidacloprid Detection in Vegetables
por: Zhai, Rongqi, et al.
Publicado: (2023) -
Clinical value of chemiluminescence method for detection of antinuclear antibody profiles
por: Xiang, Hui-Yao, et al.
Publicado: (2023)